Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2Spina Bifida Occulta 1Neural Tube Defects 1Neoplasms 1Lipomyelomeningocele 1Cerebrospinal Fluid Leak 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Prone Position × Clear all
NCT01867268 2015-04-21

Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence

Tehran University of Medical Sciences

Phase 2 Unknown
144 enrolled

Lipomyelomeningocele, Neoplasms, Neural Tube Defects, Spina Bifida Occulta, Cerebrospinal Fluid Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡